Works matching DE "THERAPEUTIC use of protease inhibitors"

Results: 702
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.

    Published in:
    HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218
    By:
    • Vingerhoets, J;
    • Calvez, V;
    • Flandre, P;
    • Marcelin, A‐G;
    • Ceccherini‐Silberstein, F;
    • Perno, C‐F;
    • Mercedes Santoro, M;
    • Bateson, R;
    • Nelson, M;
    • Cozzi‐Lepri, A;
    • Grarup, J;
    • Lundgren, J;
    • Incardona, F;
    • Kaiser, R;
    • Sonnerborg, A;
    • Clotet, B;
    • Paredes, R;
    • Günthard, HF;
    • Ledergerber, B;
    • Hoogstoel, A
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy Body fat distribution in HIV-infected patients treated for 96 weeks with darunavir/ritonavir monotherapy versus darunavir/ritonavir plus nucleoside reverse transcriptase inhibitors: the MONOI-ANRS136 Substudy

    Published in:
    HIV Medicine, 2012, v. 13, n. 8, p. 505, doi. 10.1111/j.1468-1293.2012.01004.x
    By:
    • Valantin, MA;
    • Kolta, S;
    • Flandre, P;
    • Algarte Genin, M;
    • Meynard, JL;
    • Ponscarme, D;
    • Slama, L;
    • Cuzin, L;
    • Kerviler, E;
    • Inaoui, R;
    • Katlama, C
    Publication type:
    Article
    33
    34

    Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy.

    Published in:
    HIV Medicine, 2011, v. 12, n. 3, p. 166, doi. 10.1111/j.1468-1293.2010.00865.x
    By:
    • Lambert, J. S.;
    • Else, L. J.;
    • Jackson, V.;
    • Breiden, J.;
    • Gibbons, S.;
    • Dickinson, L.;
    • Back, D. J.;
    • Brennan, M.;
    • Connor, E. O.;
    • Boyle, N.;
    • Fleming, C.;
    • Coulter-Smith, S.;
    • Khoo, S. H.
    Publication type:
    Article
    35
    36
    37
    38
    39

    Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy

    Published in:
    HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x
    By:
    • Lambert-Niclot, S.;
    • Machouf, N.;
    • Peytavin, G.;
    • Soulie, C.;
    • Wirden, M.;
    • Simon, A.;
    • Murphy, R. L.;
    • Katlama, C.;
    • Thomas, R.;
    • Calvez, V.;
    • Marcelin, A.-G.
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50